SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading…
- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society…
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All Prespecified Subgroups Company to…
With Capacity Provided by Allianz, Active Insurance is Now Available to Businesses up to €1 Billion in Revenue on a…
PrecivityAD2™ blood test now available in over seven additional countries with primary focus on regions with inadequate PET infrastructureST. LOUIS--(BUSINESS…
KOLKATA, India, July 28, 2025 /PRNewswire/ -- In a landmark achievement, a 60-year-old woman with advanced primary peritoneal carcinomatosis was…
Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of…
MIAMI, July 12, 2025 (GLOBE NEWSWIRE) -- MSP Recovery Law Firm, counsel to MSP Recovery and its affiliated healthcare clients,…
Landmark legislation enables HSA use with Bronze/Catastrophic ACA plans, telehealth, and Direct Primary Care—bringing healthcare savings into the modern era.SAN…
Reference is made to the stock exchange notice from IDEX Biometrics ASA on 15 June 2025 regarding the share issue…